COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu […]

Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stage ssorensen Mon, […]

COVID-19 tracker: Adamis’ COVID-19 trial with Tempol is a go; Brutal omicron surge sweeps through Hong Kong admin […]

A clinical trial has shown that the immunotherapy drug pembrolizumab increased survival rates for head and neck cancer […]

Recently published research determined that the Epic Systems Corporation Sepsis Model—a widely implemented electronic health record (EHR) based […]

Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies

Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan

Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win fkansteiner Mon, 02/28/2022 – 10:52

Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refiling esagonowsky Mon, 02/28/2022 – 10:34

Bristol Myers’ Opdivo steps in FDA fast lane for potential first-in-class nod in pre-surgery lung cancer aliu Mon, […]